PM
BSX icon

Parametrica Management’s Boston Scientific BSX Stock Holding History

Parametrica Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,834
Closed -$417K – 248
2017
Q4 		$417K Buy
+16,834
New +$464K 0.26% 97
2017
Q3 		– Sell
-7,887
Closed -$219K – 358
2017
Q2 		$219K Buy
+7,887
New +$209K 0.21% 211

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Parametrica Management's BSX Position: Q1 2018 in Review

Parametrica Management sold out of Boston Scientific (BSX) in Q1 2018, closing a stake of 16,834 shares — an estimated $417K sold.

Parametrica Management first reported a position in BSX in Q2 2017 and held it in 2 quarters. The position peaked at $417K in Q4 2017. 633 funds tracked by Wall St. Rank hold BSX as of Q1 2018.

  • Parametrica Management reported no remaining Boston Scientific position as of Q1 2018 after selling out during the quarter.
  • Parametrica Management sold 16,834 Boston Scientific shares in Q1 2018, an estimated $417K.
  • Parametrica Management first reported a position in Boston Scientific in Q2 2017 and held it in 2 quarters.
  • Parametrica Management's Boston Scientific position peaked at $417K in Q4 2017.
  • 633 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2018.

Based on Parametrica Management's 13F filing for Q1 2018, filed 24 Apr 2018.